Thulium laser vaporesection versus transurethral electrovaporization of the prostate in high-risk patients with benign prostatic hyperplasia

Photomedicine and Laser Surgery

Volumn 30, Issue 12, 2012, Pages 714-718

  Zhu, Zhaowei ^a   Shen, Zhoujun ^a   Tu, Fanzhuo ^a   Zhu, Yu ^a   Sun, Fukang ^a   Shao, Yuan ^a   Wang, Haofei ^a   Zhong, Shan ^a   Xu, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN PROSTATIC HYPERPLASIA; BLADDER OUTLET OBSTRUCTIONS; HIGH-RISK PATIENTS; INTERNATIONAL PROSTATE SYMPTOM SCORES; OBSERVATION PERIOD; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; THULIUM LASER; TISSUE ABLATIONS; TRANSURETHRAL;

DIAGNOSIS; FLOW RATE; HOSPITALS; LASER SAFETY; LASERS; PATIENT TREATMENT; THULIUM; VAPORS;

UROLOGY;

THULIUM;

AGED; ARTICLE; BLADDER OBSTRUCTION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MIDDLE AGED; OPERATION DURATION; PATHOPHYSIOLOGY; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

AGED; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; OPERATIVE TIME; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; THULIUM; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY BLADDER NECK OBSTRUCTION;

EID: 84870455243     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2012.3316     Document Type: Article

References (21)

1. Wasson, J.H., Reda, D.J., Bruskewitz, R.C., Elinson, J., Keller, A.M., and Henderson, W.G. (1995). A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N. Engl. J. Med. 332, 75-79.
2. Ahyai, S.A., Gilling, P., Kaplan, S.A., et al. (2010). Metaanalysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur. Urol. 58, 384-397.
3. Gilling, P.J., Wilson, L.C., King, C.J., Westenberg, A.M., Frampton, C.M., and Fraundorfer, M.R. (2012). Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: Results at 7 years. BJU Int. 109, 408-411.
4. Malde, S., Rajagopalan, A., Patel, N., Simoes, A., Choi, W., and Shrotri, N. (2012). Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J. Endourol. 26, 878-883.
5. Hammadeh, M.Y., Madaan, S., Hines, J., and Philp, T. (2003). 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection. Urology 61, 1166-1171.
6. Hammadeh, M.Y., Madaan, S., Singh, M., and Philp, T. (1998). Two-year follow-up of a prospective randomised trial of electrovaporization versus resection of prostate. Eur. Urol. 34, 188-192.
7. Bach, T., Wendt-Nordahl, G., Michel, M.S., Herrmann, T.R., and Gross, A.J. (2009). Feasibility and efficacy of Thulium: YAG laser enucleation (VapoEnucleation) of the prostate. World J. Urol. 27, 541-545.
8. Fu, W.J., Zhang, X., Yang, Y., et al. (2010). Comparison of 2-Micron continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: A prospective nonrandomized trial with 1-year follow-up. Urology 75, 194-199.
9. Si, J., Gu, B., Yu, J., and Xu, Y. (2011). The RevoLix 2 micron continuous wave laser vaporesection for the treatment of high-risk patients with benign prostatic hyperplasia. Photomed. Laser Surg. 29, 105-107.
10. Xia, S.J., Zhuo, J., Sun, X.W., Han, B.M., Shao, Y., and Zhang, Y.N. (2008). Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial. Eur. Urol. 53, 382-389.
11. Kaplan, S.A., and Te, A.E. (1995). Transurethral electrovaporization of the prostate: A novel method for treating men with benign prostatic hyperplasia. Urology 45, 566-572.
12. Mamoulakis, C., Efthimiou, I., Kazoulis, S., Christoulakis, I., and Sofras, F. (2011). The modified Clavien classification system: A standardized platform for reporting complications in transurethral resection of the prostate. World J. Urol. 29, 205-210.
13. Hruza, M., Weiss, H.O., Pini, G., et al. (2010). Complications in 2200 consecutive laparoscopic radical prostatectomies: Standardised evaluation and analysis of learning curves. Eur. Urol. 58, 733-741.
14. McVary, K.T., Roehrborn, C.G., Avins, A.L., et al. (2011). Update on AUA guideline on the management of benign prostatic hyperplasia. J. Urol. 185, 1793-1803.
15. Nuhoglu, B., Ayyildiz, A., Fidan, V., Ersoy, E., Huri, E., and Germiyanogu, C. (2005). Transurethral electrovaporization of the prostate: Is it any better than standard transurethral prostatectomy 5-year follow-up. J. Endourol. 19, 79-82.
16. Reich, O., Schlenker, B., Gratzke, C., et al. (2010). Plasma vaporisation of the prostate: Initial clinical results. Eur. Urol. 57, 693-697.
17. Bach, T., Herrmann, T.R., Ganzer, R., Burchardt, M., and Gross, A.J. (2007). RevoLix vaporesection of the prostate: Initial results of 54 patients with a 1-year follow-up. World J. Urol. 25, 257-262.
18. Szlauer, R., Gotschl, R., Razmaria, A., Paras, L., and Schmeller, N.T. (2009). Endoscopic vaporesection of the prostate using the continuous-wave 2-Microm thulium laser: Outcome and demonstration of the surgical technique. Eur. Urol. 55, 368-375.
19. Bach, T., Herrmann, T.R., Haecker, A., Michel, M.S., and Gross, A. (2009). Thulium:yttrium-Aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int. 104, 361-364.
20. Fu, W.J., Hong, B.F., Yang, Y., et al. (2009). Vaporesection for managing benign prostatic hyperplasia using a 2-Microm continuous-wave laser: A prospective trial with 1-year follow-up. BJU Int. 103, 352-356.
21. Abdel-Khalek, M., El-Hammady, S., el-H, I. (2003). A 4-year follow-up of a randomized prospective study comparing transurethral electrovaporization of the prostate with neodymium: YAG laser therapy for treating benign prostatic hyperplasia. BJU Int. 91, 801-805.